Difference between revisions of "Template:Introduction of first-generation birth control pills"

From blackwiki
Jump to navigation Jump to search
imported>Medgirl131
 
(5 intermediate revisions by the same user not shown)
Line 1: Line 1:
{| class="wikitable sortable mw-collapsible {{{state<includeonly>|mw-collapsed</includeonly>}}}" style="font-size:small; margin-left: auto; margin-right: auto; border: none;"
+
{| class="wikitable sortable mw-collapsible {{{state<includeonly>|mw-collapsed</includeonly>}}}" style="margin-left: auto; margin-right: auto; border: none;"
|+ class="nowrap" | {{Navbar|Introduction of first-generation oral contraceptives|mini=y}} {{Resize|105%|Introduction of first-generation oral contraceptives}}
+
|+ class="nowrap" | {{Navbar|Introduction of first-generation birth control pills|mini=y}} Introduction of first-generation birth control pills
 
|-
 
|-
 
! Progestin !! Estrogen !! Brand name !! Manufacturer !! U.S. Approval !! U.K. Approval
 
! Progestin !! Estrogen !! Brand name !! Manufacturer !! U.S. Approval !! U.K. Approval
Line 10: Line 10:
 
| [[Norethisterone]] || [[Ethinylestradiol]] || Norlestrin || [[Syntex]]/[[Parke-Davis]] || 1964 || 1962
 
| [[Norethisterone]] || [[Ethinylestradiol]] || Norlestrin || [[Syntex]]/[[Parke-Davis]] || 1964 || 1962
 
|-
 
|-
| [[Lynestrenol]] || [[Mestranol]] || Lyndiol || [[Organon International|Organon]] || N/A || 1963
+
| [[Lynestrenol]] || [[Mestranol]] || Lyndiol || [[Organon International|Organon]] || || 1963
 
|-
 
|-
| [[Megestrol acetate]] || [[Ethinylestradiol]] || Volidan, Nuvacon || [[British Drug Houses]] || N/A || 1963
+
| [[Megestrol acetate]] || [[Ethinylestradiol]] || Volidan, Nuvacon || [[British Drug Houses]] || || 1963
 
|-
 
|-
| [[Norethisterone acetate]] || [[Ethinylestradiol]] || Norlestrin || [[Parke-Davis]] || 1964 || {{abbr|N/D|No data}}
+
| [[Norethisterone acetate]] || [[Ethinylestradiol]] || Norlestrin || [[Parke-Davis]] || 1964 || ?
 
|-
 
|-
| [[Quingestanol acetate]] || [[Ethinylestradiol]] || Riglovis || Vister || N/A || N/A
+
| [[Quingestanol acetate]] || [[Ethinylestradiol]] || Riglovis || Vister || ||
 
|-
 
|-
| [[Quingestanol acetate]] || [[Quinestrol]] || Unovis || [[Warner Chilcott]] || N/A || N/A
+
| [[Quingestanol acetate]] || [[Quinestrol]] || Unovis || [[Warner Chilcott]] || ||
 
|-
 
|-
| [[Medroxyprogesterone acetate]] || [[Ethinylestradiol]] || Provest || [[Upjohn]] || 1964 || N/A
+
| [[Medroxyprogesterone acetate]] || [[Ethinylestradiol]] || Provest || [[Upjohn]] || 1964 ||
 
|-
 
|-
 
| [[Chlormadinone acetate]] || [[Mestranol]] || C-Quens || [[Merck & Co.|Merck]] || 1965 || 1965
 
| [[Chlormadinone acetate]] || [[Mestranol]] || C-Quens || [[Merck & Co.|Merck]] || 1965 || 1965
 
|-
 
|-
| [[Dimethisterone]] || [[Ethinylestradiol]] || Oracon || [[British Drug Houses]] || 1965 || N/A
+
| [[Dimethisterone]] || [[Ethinylestradiol]] || Oracon || [[British Drug Houses]] || 1965 ||
 
|-
 
|-
 
| [[Etynodiol diacetate]] || [[Mestranol]] || Ovulen || [[G.D. Searle, LLC|Searle]] || 1966 || 1965
 
| [[Etynodiol diacetate]] || [[Mestranol]] || Ovulen || [[G.D. Searle, LLC|Searle]] || 1966 || 1965
Line 30: Line 30:
 
| [[Etynodiol diacetate]] || [[Ethinylestradiol]] || Demulen || [[G.D. Searle, LLC|Searle]] || 1970 || 1968
 
| [[Etynodiol diacetate]] || [[Ethinylestradiol]] || Demulen || [[G.D. Searle, LLC|Searle]] || 1970 || 1968
 
|-
 
|-
| [[Norgestrienone]] || [[Ethinylestradiol]] || Planor, Miniplanor || [[Roussel Uclaf]] || N/A || N/A
+
| [[Norgestrienone]] || [[Ethinylestradiol]] || Planor, Miniplanor || [[Roussel Uclaf]] || ||
 
|-
 
|-
 
| [[Norgestrel]] || [[Ethinylestradiol]] || Ovral || [[Wyeth]] || 1968 || 1972
 
| [[Norgestrel]] || [[Ethinylestradiol]] || Ovral || [[Wyeth]] || 1968 || 1972
 
|-
 
|-
| [[Anagestone acetate]] || [[Mestranol]] || Neo-Novum || [[Ortho Pharmaceutical|Ortho]] || N/A || N/A
+
| [[Anagestone acetate]] || [[Mestranol]] || Neo-Novum || [[Ortho Pharmaceutical|Ortho]] || ||
 
|-
 
|-
| [[Lynestrenol]] || [[Ethinylestradiol]] || Lyndiol || [[Organon International|Organon]] || N/A || 1969
+
| [[Lynestrenol]] || [[Ethinylestradiol]] || Lyndiol || [[Organon International|Organon]] || || 1969
 
|- class="sortbottom"
 
|- class="sortbottom"
| colspan="6" style="width: 1px;" | '''Sources:''' ''Main:'' <ref name="Marks2001_">{{cite book|author=Lara Marks|title=Sexual Chemistry: A History of the Contraceptive Pill|url=https://books.google.com/books?id=GgvLA3bqwnoC&pg=PA77|year=2001|publisher=Yale University Press|isbn=978-0-300-08943-1|pages=73–75, 77–78}}</ref><ref name="Gelijns1991_">{{cite book|author=Annetine Gelijns|title=Innovation in Clinical Practice: The Dynamics of Medical Technology Development|url=https://books.google.com/books?id=MZkrAAAAYAAJ&pg=PA167|year=1991|publisher=National Academies|pages=167–|id=NAP:13513}}</ref><ref name="Blum2013_">{{cite book|author=Robert W. Blum|title=Adolescent Health Care: Clinical Issues|url=https://books.google.com/books?id=36PpAgAAQBAJ&pg=PA216|date=22 October 2013|publisher=Elsevier Science|isbn=978-1-4832-7738-7|pages=216–}}</ref><ref name="ToneWatkins2007_">{{cite book|author1=Andrea Tone|author2=Elizabeth Siegel Watkins|title=Medicating Modern America: Prescription Drugs in History|url=https://books.google.com/books?id=M2sTCgAAQBAJ&pg=PA117|date=8 January 2007|publisher=NYU Press|isbn=978-0-8147-8301-6|pages=117–119}}</ref> ''Supplementary:'' <ref name="McGuire2000_">{{cite book|author=John L. McGuire|title=Pharmaceuticals, 4 Volume Set|url=https://books.google.com/books?id=uG9qAAAAMAAJ|year=2000|publisher=Wiley|isbn=978-3-527-29874-7|page=1580,1599}}</ref><ref name="Rao1998_">{{cite book|author=Bhasker Rao|title=Clinical Gynecology (4Th Edition)|url=https://books.google.com/books?id=rGSR8UaOEKkC&pg=PA163|date=1 January 1998|publisher=Orient Blackswan|isbn=978-81-250-1622-9|pages=163–}}</ref><ref name="Labhart2012_">{{cite book|author=A. Labhart|title=Clinical Endocrinology: Theory and Practice|url=https://books.google.com/books?id=DAgJCAAAQBAJ&pg=PA571|date=6 December 2012|publisher=Springer Science & Business Media|isbn=978-3-642-96158-8|pages=571–}}</ref>
+
| colspan="6" style="width: 1px; background-color:#eaecf0; text-align: center;" | '''Sources:''' <noinclude>''Main:'' <ref name="Marks2001">{{cite book|author=Lara Marks|title=Sexual Chemistry: A History of the Contraceptive Pill|url=https://books.google.com/books?id=GgvLA3bqwnoC&pg=PA77|year=2001|publisher=Yale University Press|isbn=978-0-300-08943-1|pages=73–75, 77–78}}</ref><ref name="Gelijns1991">{{cite book|author=Annetine Gelijns|title=Innovation in Clinical Practice: The Dynamics of Medical Technology Development|url=https://books.google.com/books?id=MZkrAAAAYAAJ&pg=PA167|year=1991|publisher=National Academies|pages=167–|id=NAP:13513}}</ref><ref name="Blum2013">{{cite book|author=Robert W. Blum|title=Adolescent Health Care: Clinical Issues|url=https://books.google.com/books?id=36PpAgAAQBAJ&pg=PA216|date=22 October 2013|publisher=Elsevier Science|isbn=978-1-4832-7738-7|pages=216–}}</ref><ref name="ToneWatkins2007">{{cite book|author1=Andrea Tone|author2=Elizabeth Siegel Watkins|title=Medicating Modern America: Prescription Drugs in History|url=https://books.google.com/books?id=M2sTCgAAQBAJ&pg=PA117|date=8 January 2007|publisher=NYU Press|isbn=978-0-8147-8301-6|pages=117–119}}</ref> ''Supplementary:'' <ref name="McGuire2000">{{cite book|author=John L. McGuire|title=Pharmaceuticals, 4 Volume Set|url=https://books.google.com/books?id=uG9qAAAAMAAJ|year=2000|publisher=Wiley|isbn=978-3-527-29874-7|page=1580,1599}}</ref><ref name="Rao1998">{{cite book|author=Bhasker Rao|title=Clinical Gynecology (4Th Edition)|url=https://books.google.com/books?id=rGSR8UaOEKkC&pg=PA163|date=1 January 1998|publisher=Orient Blackswan|isbn=978-81-250-1622-9|pages=163–}}</ref><ref name="Labhart2012">{{cite book|author=A. Labhart|title=Clinical Endocrinology: Theory and Practice|url=https://books.google.com/books?id=DAgJCAAAQBAJ&pg=PA571|date=6 December 2012|publisher=Springer Science & Business Media|isbn=978-3-642-96158-8|pages=571–}}</ref></noinclude><includeonly>See template.</includeonly>
 
|}<!--
 
|}<!--
  

Latest revision as of 20:52, 5 February 2020

Introduction of first-generation birth control pills

Progestin Estrogen Brand name Manufacturer U.S. Approval U.K. Approval
Noretynodrel Mestranol Enovid Searle 1960 1963
Norethisterone Mestranol Ortho-Novum, Norinyl Syntex/Ortho 1963 1966
Norethisterone Ethinylestradiol Norlestrin Syntex/Parke-Davis 1964 1962
Lynestrenol Mestranol Lyndiol Organon 1963
Megestrol acetate Ethinylestradiol Volidan, Nuvacon British Drug Houses 1963
Norethisterone acetate Ethinylestradiol Norlestrin Parke-Davis 1964 ?
Quingestanol acetate Ethinylestradiol Riglovis Vister
Quingestanol acetate Quinestrol Unovis Warner Chilcott
Medroxyprogesterone acetate Ethinylestradiol Provest Upjohn 1964
Chlormadinone acetate Mestranol C-Quens Merck 1965 1965
Dimethisterone Ethinylestradiol Oracon British Drug Houses 1965
Etynodiol diacetate Mestranol Ovulen Searle 1966 1965
Etynodiol diacetate Ethinylestradiol Demulen Searle 1970 1968
Norgestrienone Ethinylestradiol Planor, Miniplanor Roussel Uclaf
Norgestrel Ethinylestradiol Ovral Wyeth 1968 1972
Anagestone acetate Mestranol Neo-Novum Ortho
Lynestrenol Ethinylestradiol Lyndiol Organon 1969
Sources: Main: [1][2][3][4] Supplementary: [5][6][7]

References

  1. Lara Marks (2001). Sexual Chemistry: A History of the Contraceptive Pill. Yale University Press. pp. 73–75, 77–78. ISBN 978-0-300-08943-1.
  2. Annetine Gelijns (1991). Innovation in Clinical Practice: The Dynamics of Medical Technology Development. National Academies. pp. 167–. NAP:13513.
  3. Robert W. Blum (22 October 2013). Adolescent Health Care: Clinical Issues. Elsevier Science. pp. 216–. ISBN 978-1-4832-7738-7.
  4. Andrea Tone; Elizabeth Siegel Watkins (8 January 2007). Medicating Modern America: Prescription Drugs in History. NYU Press. pp. 117–119. ISBN 978-0-8147-8301-6.
  5. John L. McGuire (2000). Pharmaceuticals, 4 Volume Set. Wiley. p. 1580,1599. ISBN 978-3-527-29874-7.
  6. Bhasker Rao (1 January 1998). Clinical Gynecology (4Th Edition). Orient Blackswan. pp. 163–. ISBN 978-81-250-1622-9.
  7. A. Labhart (6 December 2012). Clinical Endocrinology: Theory and Practice. Springer Science & Business Media. pp. 571–. ISBN 978-3-642-96158-8.